Logo_AIHTA
  • English
            Menu_button
                        • Oncology
                                          Video
                                          Video: What is HTA?    
                                          • Home
                                          • Research areas
                                          • Oncology

                                          Oncology

                                          21

                                          These AIHTA assessments evaluate the efficacy and safety of (new) cancer drugs  to facilitate evidence-based decision-making.

                                          Research projects

                                          Onkophade
                                          ©stock.adobe.com

                                          Oncological Breast Cancer Care in Selected European Countries - Organisation of healthcare infrastructures and medical service provision

                                          Project leaders: /page/nicole-groessmann/en

                                          Project team: /page/nicole-groessmann/en, /page/christoph-strohmaier/en, /page/michaela-riegelnegg/en

                                          Duration: Mid-April 2024 – Mid-November 2024
                                          Language: Englisch (with German summary)
                                          Publication: HTA Project Report No. 162: https://eprints.aihta.at/1545/

                                           

                                          More...

                                          Adobestock-264021599-von-thecaption9999
                                          ©stock.adobe.com

                                          Lung cancer screening in risk groups Systematic review(s) of effectiveness and utility (part 1) Costs and budgetary consequences (part 2)

                                          Project leaders: Claudia Wild (part 1), Ingrid Zechmeister-Koss (part 2)
                                          Project team:
                                          - Thomas Semlitsch (IAVEM) & EUnetHTA partners (IQWIG, potentially others) (part 1)
                                          - Christan Böhler, Sarah Wolf (part 2)
                                          Duration: May 2020 – November 2020
                                          Language: English with German summary

                                          Publications: 
                                          HTA Project report No. 132a: http://eprints.aihta.at/1282/ (part 1)
                                          HTA Projektbericht Nro 132b: https://eprints.aihta.at/1283 (part 2)

                                          More...

                                          Fotolia-110033217-s

                                          Stereotactic radiotherapy (Cyberknife®), proton beam therapy and irreversible (electroporation Nanoknife®) for localised prostate cancer (PCa): a systematic review

                                          Project leaders: /page/claudia-wild/en

                                          Project team: Louise Schmidt, Pia Lohr
                                          Suggested by: Main Association of the Austrian Social Security Institutions
                                          Duration: February 2018 – June 2018
                                          Language: German (with English summary)
                                          Publication: LBI-HTA Project report No. 107: https://eprints.aihta.at/1165

                                          More...

                                          Fotolia-45417819-xs4

                                          Health Services Research (HSR) in oncology in a selected indication: Cancer therapies for lung patients

                                          Project team: /page/nicole-groessmann/en

                                          Support in data evaluation and processing: DexHelpp
                                          Duration: October 2018 – December 2019

                                          More...

                                          Fotolia-45417819-xs2

                                          Health Services Research (HSR) in oncology: end-of-life therapies

                                          Project leaders: /page/martin-robausch/en

                                          Project team: /page/martin-robausch/en

                                          Supported by DexHelpp (data-requirements and -acquisition), Nicole Grössmann
                                          Duration: January 2018 – March 2020
                                          Publication: LBI-HTA Project report No. 127: http://eprints.aihta.at/1233

                                          More...

                                          Fotolia-45417819-xs3

                                          Health Services Research (HSR) in oncology: Analysis of Austrian data

                                          Project leaders: /page/nicole-groessmann/en

                                          Project team: /page/nicole-groessmann/en

                                          Supported by DexHelpp (data-requirements and -acquisition), Martin Robausch
                                          Duration: January 2018 – December 2019

                                          Publication:

                                          Grössmann N, Robausch M, Willenbacher W, Wolf S, Simon J, Wild C. “Magnitude of clinical benefit” of solid tumour drugs and their real-world application in the Austrian health care setting. Journal of Cancer Policy. 2020;25:100235.

                                          More...

                                          Fotolia-45417819-xs

                                          Clinical benefit of oncology drugs – Contrasting the evidence of clinically relevant endpoints three years after EMA approval

                                          Project leaders: /page/nicole-groessmann/en

                                          Project team: /page/nicole-groessmann/en

                                          Duration: December 2017 – March 2020

                                          Publications:

                                          Grössmann N, Robausch M, Rothschedl E, Wild C, Simon J (2019): Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal of Cancer. 2020;129:23-31.

                                          Grössmann N, Robausch M, Rosian K, Wild C, Simon J (2019): Monitoring evidence on overall survival benefits of anti-cancer drugs approved by the European Medicines Agency between 2009 and 2015. European Journal of Cancer 2019; 110:1-7.

                                          More...

                                          Fotolia_40910836_L

                                          Positron emission tomography/ Computer tomography (PET/ CT): need-assessment for planning

                                          Project leaders: /page/claudia-wild/en

                                          Project team: /page/claudia-wild/en

                                          Duration: September 2014 - December 2014
                                          Publication: LBI-HTA Project report No. 77: https://eprints.aihta.at/1045

                                           
                                           
                                           
                                           
                                           
                                           
                                           

                                          More...

                                          21

                                          Horizon scanning in oncology

                                          Project leaders: /page/nicole-groessmann/en, /page/sarah-wolf/en

                                          Project team: /page/sarah-wolf/en, /page/eleen-rothschedl/en, /page/nicole-groessmann/en

                                          Duration: since Oktober 2009

                                          More...

                                          21

                                          Appraisal of the quality and accuracy of written consumer health information for patients with chronic myeloid leukaemia on treatment-regimens with dasatinib, nilotinib or imatinib

                                          Project leaders: /page/claudia-wild/en

                                          Project team: Katharina Hintringer, Jone Gerdvilate
                                          Duration: April 2011 - February 2012

                                          More...

                                          « < 1 2 > »
                                          Displaying results 1 to 10.
                                                                                                              Netzwerk
                                                                                                              • Eunethta
                                                                                                              • Ebm
                                                                                                              • Inahta
                                                                                                              • Dexhelpp
                                                                                                              Shareholder
                                                                                                              • Bmfg
                                                                                                              • Sv
                                                                                                              • Wgfond
                                                                                                              • Noe
                                                                                                              • Ooghfond
                                                                                                              • Ghls
                                                                                                              • Tirol
                                                                                                              • Vorarlberg
                                                                                                              • Kghfond
                                                                                                              • Ghpf
                                                                                                              • Burgef
                                                                                                                        © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                        • Log in